GLP-1 Agonists GLP-1 agonists, such as semaglutide (Ozempic, Wegovy), have become incredibly popular for their powerful effects on weight loss
Ethics declarations Ethics approval and consent to participate All experiments with brain organoids were performed in accordance with the national and international ethics guidelines, and were approved by the ethics committee at the University of Luxembourg, Comit National dEthique de Recherche (CNER
Sugary Cereals: Many breakfast cereals are high in sugar and lack nutritional value
This can ultimately lead to serious health problems, including nerve damage, kidney disease, and blindness
Treating older people with semaglutide has shown positive results
Age 25 has been suggested as a cutoff for India